ReviewCost effectiveness and resource allocation : C/E2023

Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in "Boao Lecheng Pilot Zone".

Jiahe Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.